Will Glaxo’s peers follow its anti-corruption lead in China?

Carly Helfand

GlaxoSmithKline, post-corruption scandal, has been working hard to clean up its act in , overhauling its sales practices to wipe out bribery–and its general manager in the country, Hervé Gisserot, has said he expects to see other companies suit. But with sales hanging in the balance, some might not be sure just how to do that.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS